Described herein is an acerola cherry (Malpighia emarginata DC.) variety designated Nutrilite Acerola Super C, plants thereof, seed thereof, hybrids thereof, products thereof, and cultivars derived therefrom. The Nutrilite Acerola Super C variety has greater fruit yield, greater fruit mass, greater productivity, greater amounts of vitamin C, greater amounts of polyphenols, greater amounts of antioxidants, improved fruit firmness, and greater juice yields, among other desirable phenotypic or genotypic characteristics, as compared to other varieties of acerola plants or wild-type acerola.
Provided is a multilayer formulation. The multilayer formulation is useful for controlled-release and immediate-release of active agents after administration to a subject. The multilayer formulation comprises a first layer comprising a controlled-release composition, and a second layer disposed adjacent the first layer and comprising an immediate-release composition. The controlled-release composition of the first layer comprises a first active agent and a controlled-release excipient comprising a modified tapioca starch. The modified tapioca starch provides for controlled-release of the first active agent from the first layer. The immediate-release composition of the second layer comprises a second active agent and an excipient. The multilayer formulation can be in the form of a tablet, such as a bilayer tablet. The multilayer formulation may be administered orally to a subject to provide various types of active agents (e.g., vitamins, minerals, botanicals, etc.) at different locations of the subject's gastrointestinal (GI) tract.
COMPOSITIONS COMPRISING CAROTENOIDS AND/OR BILBERRY FOR PROTECTING THE EYES OF A MAMMALIAN SUBJECT FROM OR REDUCING OR TREATING DAMAGE DUE TO EXPOSURE TO BLUE LIGHT
Described herein are methods and compositions that comprise an amount of at least one active agent, such as at least one carotenoid and an ingredient or extract of bilberry, preferably an amount of at least one of: lutein, zeaxanthin, β-carotene, lycopene, and an ingredient or extract of bilberry; and an additive.
A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A composition for administration to a subject is provided. The composition comprises at least one botanical active component present in an amount effective to inhibit on or more of α-glucosidase, lipase, and xanthine oxidase in the subject. The botanical active component comprises, consists essentially of, or is Mongolidine F. The composition may be in the form of an oral composition, e.g., for ingestion, or in the form of a topical composition, e.g., for topical application. Use of the composition for inhibiting at least one of α-glucosidase, lipase, and xanthine oxidase in a subject, and use of the composition in preparing a medicine for treatment of at least one of hyperglycemia, hyperlipidemia, and hyperuricemia, are also provided. A method of inhibiting at least one of α-glucosidase, lipase, and xanthine oxidase in a subject is also provided. The method comprises administering an effective amount of the composition to the subject.
NN 1NN 10-caffeoylspermidine that maintains cell viability for subsequent exposure to UVB radiation and repairs genetic damage caused by UVB radiation is provided.
Provided herein are compositions and method for treating and preventing skin damage. In particular, provided herein are compositions that reverse, prevent and/or slow age-related skin damage.
A system and method for automating the identification of botanicals and detection of adulterants based on High Performance Thin-Layer Chromatography ("HPTLC") images. The system and method includes a first neural network that augments an existing HPTLC image dataset with synthetic data created using an adversarial machine learning model. For example, the synthetic data may be created using a generative adversarial network (GAN). The system and method further includes a second neural network that is trained on a combination of real data and synthetic data produced by the adversarial machine learning model. For example, the second neural network may be a deep convolutional neural network (CNN). Following training, the CNN performs the identification of botanicals and detection of adulteration through machine vision-based analysis of the output image data corresponding to phytochemical composition from HPTLC. The system may provide confidence-based probabilities and other numerical outputs related to the identify and adulteration determinations.
Described herein are methods and compositions for use in treating, preventing or reversing aging or age-related diseases, disorders or conditions. Also, described herein are methods and compositions for selective killing of senescent cells that are associated with numerous pathologies and diseases, including age-related pathologies, diseases and conditions. As disclosed herein are methods where senescent cell associated diseases and disorders may be treated or prevented (i.e., likelihood of occurrence or development is reduced) by administering the described compositions.
A61K 36/82 - Theaceae (famille du théier), p. ex. camélia
A61K 8/97 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base d’algues, de champignons, de lichens ou de plantesCosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de leurs dérivés
A liquid chemical applicator used for scalp care is provided. The liquid chemical applicator includes a container accommodating liquid chemical, an inner cap coupled to the container, and an outer cap rotatably and movably coupled to the inner cap. The inner cap includes a bush portion coupled to an outlet hole of the container along a central axis of the outlet hole. The outer cap includes a plug portion blocking and opening the bush portion, and further discharges the liquid chemical introduced through the bush portion. The outer cap blocks or opens the bush portion by rotation in first and second rotation directions centered on the central axis and by movement in first and second movement directions along the central axis.
B65D 47/14 - Fermetures avec dispositifs de décharge autres que des pompes avec goulottes ou tubes de déversementFermetures avec dispositifs de décharge autres que des pompes avec tuyères ou passages pour la décharge ayant des fermetures amovibles et des moyens de retenir la fermeture
B65D 47/12 - Fermetures avec dispositifs de décharge autres que des pompes avec goulottes ou tubes de déversementFermetures avec dispositifs de décharge autres que des pompes avec tuyères ou passages pour la décharge ayant des fermetures amovibles
10.
SYSTEM AND METHOD FOR AUTONOMOUS BOTANICAL IDENTIFICATION AND ADULTERATION DETECTION
A system and method for automating the identification of botanicals and detection of adulterants based on High Performance Thin-Layer Chromatography (“HPTLC”) images. The system and method includes a first neural network that augments an existing HPTLC image dataset with synthetic data created using an adversarial machine learning model. For example, the synthetic data may be created using a generative adversarial network (GAN). The system and method further includes a second neural network that is trained on a combination of real data and synthetic data produced by the adversarial machine learning model. For example, the second neural network may be a deep convolutional neural network (CNN). Following training, the CNN performs the identification of botanicals and detection of adulteration through machine vision-based analysis of the output image data corresponding to phytochemical composition from HPTLC. The system may provide confidence-based probabilities and other numerical outputs related to the identify and adulteration determinations.
Potentilla glabraPotentilla glabra; ii) thonningianin A; and iii) combinations of i) and ii). The composition may be in the form of an oral composition, e.g., for ingestion. The composition may also be in the form of a topical composition, e.g., for topical application. A method of inhibiting 5α-reductase in a subject is also provided. The method comprises administering an effective amount of the composition to the subject.
A61K 36/73 - Rosaceae (famille de la rose), p. ex. fraise, aronia, mûre ou pyracantha
A61K 31/7034 - Composés ayant des radicaux saccharide liés à des composés non-saccharide par des liaisons glycosidiques liés à un composé carbocyclique, p. ex. phloridzine
A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
A method of preparing a Polygonatum polysaccharide composition is provided. The method includes performing a first extraction of Polygonatum material to obtain a first residue; performing a second extraction of the first residue to obtain a second residue; performing a third extraction of the second residue to obtain a supernatant, and precipitating the supernatant with a solvent to obtain crude polysaccharides; performing elution of the crude polysaccharides with a first eluent to obtain a first eluate; and performing filtration of the first eluate. A Polygonatum polysaccharide composition obtained by the method, an oral composition including the Polygonatum polysaccharide composition, a use of the Polygonatum polysaccharide composition in preparing a medicine for treatment of ulcerative colitis (UC) in a subject, and a method of treating UC in a subject are also provided. The Polygonatum polysaccharide composition comprises, consists essentially of, or is an isolated polysaccharide of a particular structure described herein.
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse
C08B 37/00 - Préparation des polysaccharides non prévus dans les groupes Leurs dérivés
C08L 5/00 - Compositions contenant des polysaccharides ou leurs dérivés non prévus dans les groupes ou
13.
METHOD OF HIGH THROUGHPUT SCREENING (HTS) FOR BIOACTIVES
A screening method for the high-throughput detection of phytochemicals is provided. The method includes exposing an extract cell group to a plant extract to form an exposed cell group. Exposed signals generated by the extract cell group and control signals generated by the control group are measured and compared to generate a signal list consisting of exposed signals that satisfy an inclusion condition. The exposed signals of the signal list are compared to a list of pre-determined phytochemical signatures to generate a known phytochemical list and/or an unknown phytochemical list. The known phytochemical list includes phytochemicals having phytochemical signatures substantially matching one of the exposed signals of the signal list, and the unknown phytochemical list consists of all other phytochemicals. A chemical database comprising phytochemical associations with chemicals to generate a reactive chemical list for each phytochemical of the known phytochemical list.
A method useful for providing a phytonutrient to a subject via mediation of the subject's microbiome is disclosed. The method includes administering a phytofunctional composition to a subject change the phytonutrient-producer status of the subject. The method may also include identifying a phytonutrient-producer status of the subject by assessing a level of at least one of a preselected phytonutrient and a preselected phytonutrient precursor compound within the subject. A phytofunctional composition useful in the method is also disclosed, and comprises a phytonutrient precursor compound and an active agent. The active agent comprises a probiotic and/or a prebiotic, and is adapted to mediate production of the preselected phytonutrient in the gastrointestinal tract of the subject, thereby changing the phytonutrient-producer status of the subject.
A61K 35/747 - Lactobacilles, p. ex. L. acidophilus ou L. brevis
A61K 31/352 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à six chaînons avec un oxygène comme seul hétéro-atome d'un cycle condensés avec des carbocycles, p. ex. cannabinols, méthanthéline
A61K 31/353 - 3,4-Dihydrobenzopyranes, p. ex. chromane, catéchine
A61K 31/7032 - Composés ayant des radicaux saccharide liés à des composés non-saccharide par des liaisons glycosidiques liés à un polyol, c.-à-d. composés ayant plusieurs groupes hydroxyle, libres ou estérifiés, y compris le groupe hydroxyle impliqué dans la liaison glycosidique, p. ex. monoglucosyl-diacylglycérides, acide lactobionique, gangliosides
A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p. ex. leucoglucosane, hespéridine, érythromycine, nystatine
A skin treatment device configured to selectively operate in hydradermabrasion mode and in massage mode. The skin treatment device includes a working end and a plurality of interchangeable working attachments that can be selectively mounted to the working end. The working attachments includes at least one hydradermabrasion tip and at least one massage head. The device includes a liquid delivery system for moving liquid from a supply canister to the working attachment and from the working attachment to the waste receptacle. The hydradermabrasion tip includes a supply aperture for delivering liquid to the target region of skin and a return aperture for returning liquid from the target region to the waste receptacle. The device may include a red-light therapy system for delivering red-light therapy to a target region. The red-light therapy system may include a plurality of red LEDs positioned to emit red light through an installed working attachment.
A cap device for scalp care is provided. The cap device includes an interior cover, an exterior cover coupled to the interior cover, a substrate, and a blower. The interior cover covers the scalp, and has emitting holes for emitting air. The exterior cover defines an air flow passage along the interior cover, and has a vent hole for sucking air. The substrate is coupled to the interior cover in the air flow passage to cover an outer surface of the interior cover. The substrate has laser diodes, infrared ray and red light emitting diodes, and through holes corresponding to the emitting holes. The blower communicates with the air flow passage at an upper end of the interior cover. The blower sucks air through the vent hole and emits the air to the scalp through the emitting holes via the air flow passage.
An Orris root extract is disclosed. The Orris root extract is obtained via Orris root materials via selective extraction, and is selectively enriched in (A) a phytochemical melanogenesis stimulating agent or (B) a phytochemical melanogenesis inhibiting agent. The phytochemical melanogenesis stimulating agent (A) comprises germanaism B, and the phytochemical melanogenesis inhibiting agent (B) comprises iriflorental and/or iripallidal. A method of preparing the Orris root extract composition is also provided, and includes selectively extracting an Orris root materials to give at least one Orris root extract. A functional composition comprising the Orris root extract is also provided. The functional composition is adapted for administration to a subject via topical application, and demonstrates activity relating to skin pigmentation.
A61K 8/33 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant de l'oxygène
Lycium ruthenicumCaenorhabditis elegansCaenorhabditis elegans is provided. The extract may include compounds that inhibit the activity of histone deacetylases and that are specific inhibitors of HDAC8.
A23L 2/02 - Boissons non alcooliséesCompositions sèches ou concentrés pour les fabriquer Leur préparation ou leur traitement contenant des jus de fruits ou de légumes
A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
Lycium ruthenicumLycium ruthenicum fruit to provide the extract as a product is further provided. A method of inhibiting a histone deacetylase is further provided.
The described invention relates to a composition for preventing, treating, or relieving menstrual symptoms or discomforts and providing mood improvement in a female patient comprising: (i) an ingredient or an extract of chasteberry fruit; (ii) an ingredient or an extract of saffron red sargol stigma, wherein the ingredient or the extract of saffron red sargol stigma is encapsulated by maltodextrin; and (iii) an excipient. The described invention also relates to a method of using the composition for prevention and amelioration of common menstrual cycle symptoms and/or discomforts in female subjects.
The described invention relates to a composition for preventing, treating, or relieving menstrual symptoms or discomforts and providing mood improvement in a female patient comprising: (i) an ingredient or an extract of chasteberry fruit; (ii) an ingredient or an extract of saffron red sargol stigma, wherein the ingredient or the extract of saffron red sargol stigma is encapsulated by maltodextrin; and (iii) an excipient. The described invention also relates to a method of using the composition for prevention and amelioration of common menstrual cycle symptoms and/or discomforts in female subjects.
A61K 36/53 - Lamiaceae ou Labiatae (famille de la menthe), p. ex. thym, romarin ou lavande
A61K 36/48 - Fabaceae ou Leguminosae (famille du pois ou des légumineuses)CaesalpiniaceaeMimosaceaePapilionaceae
A61P 15/08 - Médicaments pour le traitement des troubles génitaux ou sexuelsContraceptifs pour les troubles gonadiques ou pour augmenter la fertilité, p. ex. inducteurs d'ovulation ou de spermatogénèse
C12N 15/11 - Fragments d'ADN ou d'ARNLeurs formes modifiées
26.
COMPOSITION FOR PROMOTING MOISTURE ABSORPTION AND RETENTION IN SKIN AND METHOD OF PREPARING THE COMPOSITION
Salvia hispanicaSalvia hispanicaSalvia hispanica seed to form a mixture; adding a bacteria strain to the mixture; subjecting the mixture to fermentation for a time period of at least 48 hours; and subjecting the fermented mixture to high pressure homogenization to form a nanoemulsion. A method of promoting moisture absorption and retention in skin of a subject is also provided. The method comprises topically administering the composition to the skin of the subject.
Potentilla glabraBombax malabaricumAmomum villosumAmomum kravanhCornus officinalis Cornus officinalis fruit; and vi) combinations of i) to v). The composition may be in the form of a topical composition, e.g., for topical application. The composition may also be in the form of an oral composition, e.g., for ingestion. A method of inhibiting elastase activity in the skin of a subject is also provided. The method comprises administering an effective amount of the composition to the subject.
Potentilla glabraBombax malabaricumAmomum kravanhCornus officinalis Cornus officinalis fruit; and v) combinations of i) to iv). The composition may be in the form of a topical composition, e.g., for topical application. The composition may also be in the form of an oral composition, e.g., for ingestion. A method of inhibiting collagenase activity in the skin of a subject is also provided. The method comprises administering an effective amount of the composition to the subject.
Dendrobium officinaleScrophularia ningpoensisEucommia ulmoidesEucommia ulmoides; and iv) combinations of i) to iii). The composition may be in the form of a topical composition, e.g., for topical application. The composition may also be in the form of an oral composition, e.g., for ingestion. A method of inhibiting advanced glycation end products (AGEs) in skin of a subject is also provided. The method comprises administering an effective amount of the composition to the subject.
Provided is a multilayer formulation. The multilayer formulation is useful for controlled-release and immediate-release of active agents after administration to a subject. The multilayer formulation comprises a first layer comprising a controlled-release composition, and a second layer disposed adjacent the first layer and comprising an immediate-release composition. The controlled-release composition of the first layer comprises a first active agent and a controlled-release excipient comprising a modified tapioca starch. The modified tapioca starch provides for controlled-release of the first active agent from the first layer. The immediate-release composition of the second layer comprises a second active agent and an excipient. The multilayer formulation can be in the form of a tablet, such as a bilayer tablet. The multilayer formulation may be administered orally to a subject to provide various types of active agents (e.g., vitamins, minerals, botanicals, etc.) at different locations of the subject's gastrointestinal (GI) tract.
A method useful for providing a phytonutrient to a subject via mediation of the subject’s microbiome is disclosed. The method includes administering a phytofunctional composition to a subject change the phytonutrient producer status of the subject. The method may also include identifying a phytonutrient producer status of the subject by assessing a level of at least one of a preselected phytonutrient and a preselected phytonutrient precursor compound within the subject. A phytofunctional composition useful in the method is also disclosed, and comprises a phytonutrient precursor compound and an active agent. The active agent comprises a probiotic and/or a prebiotic, and is adapted to mediate production of the preselected phytonutrient in the gastrointestinal tract of the subject, thereby changing the phytonutrient producer status of the subject.
A61K 35/747 - Lactobacilles, p. ex. L. acidophilus ou L. brevis
A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p. ex. leucoglucosane, hespéridine, érythromycine, nystatine
A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
A61K 31/7032 - Composés ayant des radicaux saccharide liés à des composés non-saccharide par des liaisons glycosidiques liés à un polyol, c.-à-d. composés ayant plusieurs groupes hydroxyle, libres ou estérifiés, y compris le groupe hydroxyle impliqué dans la liaison glycosidique, p. ex. monoglucosyl-diacylglycérides, acide lactobionique, gangliosides
A61K 31/352 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à six chaînons avec un oxygène comme seul hétéro-atome d'un cycle condensés avec des carbocycles, p. ex. cannabinols, méthanthéline
A61K 31/353 - 3,4-Dihydrobenzopyranes, p. ex. chromane, catéchine
A UV reactor for disinfecting water and including a UV source printed circuit board assembly transfers heat to a heat sink in the form of a water facing thermal coupler. The UV source printed circuit board assembly may include a metal clad printed circuit board having a thermal contact region in thermal communication with the heat sink.
Provided herein are compositions and method for treating and preventing skin damage In particular, provided herein re compositions that reverse, prevent and/or slow age-related skin damage.
A cap device for scalp care is provided. The cap device comprises an inner cover, an outer cover coupled to the inner cover, a substrate, and a blower. The inner cover covers the scalp, and has an ejection hole for ejecting air. The outer cover defines an airflow passage along the inner cover, and has a ventilation hole for sucking in air. The substrate is coupled to the inner cover so as to cover the outer surface of the inner cover in the airflow passage. The substrate has a laser diode, infrared and red light emitting diodes, and a through hole corresponding to the ejection hole. The blower communicates with the airflow passage at the top end of the inner cover. The blower sucks in air through the ventilation hole, and ejects the air to the scalp through the ejection hole via the airflow passage.
An Orris root extract is disclosed. The Orris root extract is obtained via Orris root materials via selective extraction, and is selectively enriched in (A) a phytochemical melanogenesis stimulating agent or (B) a phytochemical melanogenesis inhibiting agent. The phytochemical melanogenesis stimulating agent (A) comprises germanaism B, and the phytochemical melanogenesis inhibiting agent (B) comprises iriflorental and/or iripallidal. A method of preparing the Orris root extract composition is also provided, and includes selectively extracting an Orris root materials to give at least one Orris root extract. A functional composition comprising the Orris root extract is also provided. The functional composition is adapted for administration to a subject via topical application, and demonstrates activity relating to skin pigmentation.
A61Q 19/02 - Préparations pour les soins de la peau pour décolorer ou blanchir la peau chimiquement
A61K 8/33 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant de l'oxygène
A UV reactor for disinfecting water. The UV reactor may include a cooling chamber in which heat from a UV source may be transferred to the water flowing through the UV reactor. The UV reactor may include driver circuitry operable to determine status information, such as health, of the UV source. The UV reactor may include a gas discharge path operable to substantially prevent accumulation of gas within a water treatment chamber.
Provided herein are compositions and method for treating and preventing skin damage. In particular, provided herein are compositions that reverse, prevent and/or slow age-related skin damage.
A61K 8/92 - Huiles, graisses ou ciresLeurs dérivés, p. ex. produits d'hydrogénation
A61K 8/97 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base d’algues, de champignons, de lichens ou de plantesCosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de leurs dérivés
A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
A water treatment system is provided with an untreated water reservoir having a cavity through which a filter assembly may traverse such that untreated water in the cavity passes through the filter assembly into a treated water reservoir. Removal of the filter assembly may be facilitated by a seal disengagement element operable to unseat a seal formed during efforts to direct untreated water through the filter assembly.
A method useful for providing a phytonutrient to a subject via mediation of the subject's microbiome is disclosed. The method includes administering a phytofunctional composition to a subject change the phytonutrient producer status of the subject. The method may also include identifying a phytonutrient producer status of the subject by assessing a level of at least one of a preselected phytonutrient and a preselected phytonutrient precursor compound within the subject. A phytofunctional composition useful in the method is also disclosed, and comprises a phytonutrient precursor compound and an active agent. The active agent comprises a probiotic and/or a prebiotic, and is adapted to mediate production of the preselected phytonutrient in the gastrointestinal tract of the subject, thereby changing the phytonutrient producer status of the subject.
A product interaction monitor includes sensors for measuring characteristics related to the product and/or product package or other type of container. The product interaction monitor can be installed in a container cap and used to monitor events associated with the container such as product usage. The product interaction monitor can utilize multiple sensor outputs to increase the accuracy of the detection of the events. The product interaction monitor can be used to estimate product inventory or product usage and communicate information regarding the product and/or product usage to a local display or a remote computer.
A61J 7/04 - Dispositions pour l'indication ou le rappel du moment où l'on doit prendre des médicaments, p. ex. distributeurs programmés
B65D 51/24 - Fermetures non prévues ailleurs combinées avec dispositifs auxiliaires pour des buts autres que la fermeture
B65D 41/04 - Capuchons ou couvercles en forme de capuchons filetés ou similaires, fixés par rotation
G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
G08B 21/24 - Alarmes aide-mémoire, p. ex. alarmes contre la perte
G16H 20/13 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients delivrés par des distributeurs
A61J 1/03 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques pour pilules ou comprimés
A61J 1/14 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques DétailsAccessoires à cet effet
52.
Method of increasing the level and production of metabolized phytonutrients in a subject
A method useful for providing a phytonutrient to a subject via mediation of the subject's microbiome is disclosed. The method includes administering a phytofunctional composition to a subject change the phytonutrient producer status of the subject. The method may also include identifying a phytonutrient producer status of the subject by assessing a level of at least one of a preselected phytonutrient and a preselected phytonutrient precursor compound within the subject. A phytofunctional composition useful in the method is also disclosed, and comprises a phytonutrient precursor compound and an active agent. The active agent comprises a probiotic and/or a prebiotic, and is adapted to mediate production of the preselected phytonutrient in the gastrointestinal tract of the subject, thereby changing the phytonutrient producer status of the subject.
A61K 35/747 - Lactobacilles, p. ex. L. acidophilus ou L. brevis
A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p. ex. leucoglucosane, hespéridine, érythromycine, nystatine
A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
A61K 31/7032 - Composés ayant des radicaux saccharide liés à des composés non-saccharide par des liaisons glycosidiques liés à un polyol, c.-à-d. composés ayant plusieurs groupes hydroxyle, libres ou estérifiés, y compris le groupe hydroxyle impliqué dans la liaison glycosidique, p. ex. monoglucosyl-diacylglycérides, acide lactobionique, gangliosides
A61K 31/352 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à six chaînons avec un oxygène comme seul hétéro-atome d'un cycle condensés avec des carbocycles, p. ex. cannabinols, méthanthéline
A61K 31/353 - 3,4-Dihydrobenzopyranes, p. ex. chromane, catéchine
A UV reactor for disinfecting water. The UV reactor may include a cooling chamber in which heat from a UV source may be transferred to the water flowing through the UV reactor. The UV reactor may include driver circuitry operable to determine status information, such as health, of the UV source. The UV reactor may include a gas discharge path operable to substantially prevent accumulation of gas within a water treatment chamber.
A UV reactor for disinfecting water. The UV reactor may include a cooling chamber in which heat from a UV source may be transferred to the water flowing through the UV reactor. The UV reactor may include driver circuitry operable to determine status information, such as health, of the UV source. The UV reactor may include a gas discharge path operable to substantially prevent accumulation of gas within a water treatment chamber.
A protein hydrolysate composition is provided. The protein hydrolysate composition comprises isolated peptides useful for ameliorating a condition of a subject. Compositions comprising the protein hydrolysate composition are also provided. The compositions may be adapted for oral or topical administration to the subject, and may compose a foodstuff or beverage (e.g. a medical food), a topical composition (e.g. a lotion, cream, etc.), a kit, and the like. A methods of ameliorating the condition of the subject is further provided. The method include administering the protein hydrolysate composition to the subject. The method may be useful in reducing blood pressure, inflammation, reduced immunity, and/or oxidative stress in the subject.
A61K 38/08 - Peptides ayant de 5 à 11 amino-acides
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
A topical composition comprising a mucilage plant extract is provided. The topical composition is formulated for administration to a subject, and may be provided in the form of a skin toner. Methods of preparing the topical composition are also provided, and include combining a mucilage plant extract and a pharmaceutically acceptable additive. The topical composition may be used to control the skin microbiome of a subject, and likewise for treating certain skin conditions involving pathogenic bacteria. A method of ameliorating a skin condition of a subject is therefore also provided. The method generally includes topically administering the topical composition to the skin of the subject, and may be used in ameliorating skin conditions including inflammation and/or decreased epidermal barrier function.
A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
A protein hydrolysate composition is provided. The protein hydrolysate composition comprises isolated peptides useful for ameliorating a condition of a subject. Compositions comprising the protein hydrolysate composition are also provided. The compositions may be adapted for oral or topical administration to the subject, and may compose a foodstuff or beverage (e.g. a medical food), a topical composition (e.g. a lotion, cream, etc.), a kit, and the like. A methods of ameliorating the condition of the subject is further provided. The method include administering the protein hydrolysate composition to the subject. The method may be useful in reducing blood pressure, inflammation, reduced immunity, and/or oxidative stress in the subject.
A water treatment system having a base assembly and a treatment assembly. The treatment assembly of the system may be configured to filter particulates from water. The base assembly may include a UV reactor operable to disinfect water for consumption.
B01D 29/15 - Éléments filtrants avec des supports agencés pour la filtration à courant dirigé vers l'intérieur
B01D 29/96 - Filtres à éléments filtrants stationnaires pendant la filtration, p. ex. filtres à aspiration ou à pression, non couverts par les groupes Leurs éléments filtrants dans lesquels les éléments filtrants sont déplacés entre les opérations de filtrationDispositions particulières pour enlever ou remplacer les éléments filtrantsSystèmes de transport pour filtres
C02F 1/00 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout
C02F 1/44 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par dialyse, osmose ou osmose inverse
C02F 1/32 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par irradiation par la lumière ultraviolette
B01D 29/11 - Filtres à éléments filtrants stationnaires pendant la filtration, p. ex. filtres à aspiration ou à pression, non couverts par les groupes Leurs éléments filtrants avec des éléments filtrants en forme de sac, de cage, de tuyau, de tube, de manchon ou analogue
A water treatment system having a base assembly and a treatment assembly. The treatment assembly of the system may be configured to filter particulates from water. The base assembly may include a UV reactor operable to disinfect water for consumption.
B01D 29/15 - Éléments filtrants avec des supports agencés pour la filtration à courant dirigé vers l'intérieur
B01D 29/96 - Filtres à éléments filtrants stationnaires pendant la filtration, p. ex. filtres à aspiration ou à pression, non couverts par les groupes Leurs éléments filtrants dans lesquels les éléments filtrants sont déplacés entre les opérations de filtrationDispositions particulières pour enlever ou remplacer les éléments filtrantsSystèmes de transport pour filtres
C02F 1/00 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout
C02F 1/44 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par dialyse, osmose ou osmose inverse
C02F 1/32 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par irradiation par la lumière ultraviolette
B01D 29/11 - Filtres à éléments filtrants stationnaires pendant la filtration, p. ex. filtres à aspiration ou à pression, non couverts par les groupes Leurs éléments filtrants avec des éléments filtrants en forme de sac, de cage, de tuyau, de tube, de manchon ou analogue
A water treatment system having a base assembly and a treatment assembly. The treatment assembly of the system may be configured to filter particulates from water. The base assembly may include a UV reactor operable to disinfect water for consumption.
C02F 1/00 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout
B01D 27/02 - Filtres à cartouches du type à jeter à cartouches constituées à partir d'une masse de substance non agglomérée
C02F 1/32 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par irradiation par la lumière ultraviolette
B65D 6/00 - Réceptacles dont le corps est formé par jonction ou liaison de plusieurs composants rigides ou sensiblement rigides, constitués en totalité ou principalement en métal, en matière plastique, en bois ou en un matériau de remplacement
F21V 8/00 - Utilisation de guides de lumière, p. ex. dispositifs à fibres optiques, dans les dispositifs ou systèmes d'éclairage
A water treatment system having a base assembly and a treatment assembly. The treatment assembly of the system may be configured to filter particulates from water. The base assembly may include a UV reactor operable to disinfect water for consumption.
B01D 29/15 - Éléments filtrants avec des supports agencés pour la filtration à courant dirigé vers l'intérieur
B01D 29/96 - Filtres à éléments filtrants stationnaires pendant la filtration, p. ex. filtres à aspiration ou à pression, non couverts par les groupes Leurs éléments filtrants dans lesquels les éléments filtrants sont déplacés entre les opérations de filtrationDispositions particulières pour enlever ou remplacer les éléments filtrantsSystèmes de transport pour filtres
C02F 1/00 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout
C02F 1/44 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par dialyse, osmose ou osmose inverse
C02F 1/32 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par irradiation par la lumière ultraviolette
B01D 29/11 - Filtres à éléments filtrants stationnaires pendant la filtration, p. ex. filtres à aspiration ou à pression, non couverts par les groupes Leurs éléments filtrants avec des éléments filtrants en forme de sac, de cage, de tuyau, de tube, de manchon ou analogue
63.
Nano-enabled activated carbon blocks to enable removal of oxyanions from water
Arizona Board of Regents on behalf of Arizona State University (USA)
Inventeur(s)
Cai, Zhenxiao
Mollema, Scott A.
Atkinson, Ariel J.
Hristovski, Kiril D.
Markovski, Jasmina S.
Westerhoff, Paul K.
Abrégé
A method for preparing a nano-enabled activated carbon block, a nano-enabled activated carbon block produced by the method, a household water filtration system comprising the nano-enabled activated carbon block, and a method for filtering tap water using the household water filtration system are provided. The method includes contacting a solution including a metal(lic) precursor (e.g. a titanium compound and/or an iron compound and/or a zirconium compound) with activated carbon particles such that the solution fills pores of the activated carbon particles. The method further includes causing a metal (hydr)oxide (e.g. titanium dioxide and/or zirconium dioxide and/or iron oxide) to precipitate from the solution thereby causing metal oxide nanoparticles to become deposited within pores of the activated carbon particles. The method also includes preparing a nano-enabled activated carbon block from the activated carbon particles having metal oxide nanoparticles deposited within the pores thereof.
B01J 20/20 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation contenant une substance inorganique contenant du carbone libreCompositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation contenant une substance inorganique contenant du carbone obtenu par des procédés de carbonisation
B01J 20/30 - Procédés de préparation, de régénération ou de réactivation
B01J 20/28 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation caractérisées par leur forme ou leurs propriétés physiques
A water treatment system is provided with an untreated water reservoir having a cavity through which a filter assembly may traverse such that untreated water in the cavity passes through the filter assembly into a treated water reservoir. Traversal of the filter assembly may be facilitated by a pressure control assembly as a vacuum pump in order to generate a vacuum in a treated water reservoir connected to the filter assembly.
A water treatment system is provided with an untreated water reservoir having a cavity through which a filter assembly may traverse such that untreated water in the cavity passes through the filter assembly into a treated water reservoir. Traversal of the filter assembly may be facilitated by a pressure control assembly configured to generate a vacuum.
C02F 1/00 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout
C02F 1/32 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par irradiation par la lumière ultraviolette
B01D 29/60 - Filtres à éléments filtrants stationnaires pendant la filtration, p. ex. filtres à aspiration ou à pression, non couverts par les groupes Leurs éléments filtrants combinés dans une même structure à des dispositifs de commande de la filtration
The present disclosure relates to a smart diffuser. The smart diffuser of the present disclosure includes a frame configured to define a diffusing position, a container mounted on the frame and including a space configured to mount a plurality of oil cartridges therein, and a driving unit configured to drive the container. The driving unit drives the container so as to cause a cartridge selected by a user among the plurality of oil cartridges to enter the diffusing position.
The present disclosure relates to a method of operating a smart diffuser using a terminal connected to the smart diffuser via a network and a terminal therefor. The method of operating the smart diffuser using the terminal includes generating a mode selection signal comprising operation information on a plurality of oil cartridges mounted in the smart diffuser, wherein the operation information comprises at least one of an operation order, an operation duration, a fragrance emission intensity, and an operation time zone of each of the cartridges; and transmitting the mode selection signal to the smart diffuser. The present disclosure relates to a method of operating a smart diffuser (200) using a terminal (100) connected to the smart diffuser (200) via a network and a terminal therefor. The method of operating the smart diffuser (200) using the terminal (100) includes generating (S 10) a mode selection signal comprising operation information on a plurality of oil cartridges (CA) mounted in the smart diffuser (200), wherein the operation information comprises at least one of an operation order, an operation duration, a fragrance emission intensity, and an operation time zone of each of the cartridges (CA); and transmitting (S20) the mode selection signal to the smart diffuser (200).
Compositions for preventing, treating and/or curing human skin from an air pollution-induced damage and methods of using the compositions are described. One embodiment relates to a cosmetic composition comprising an isolated ingredient or an extract of Dendrobium nobile, in a working amount sufficient for at least one of: reducing or preventing air pollution-induced or air pollution inducible skin and/or hair damage; reducing or preventing air pollution-induced oxidative stress; reducing or preventing air pollution-induced decrease in cell vitality; reducing or preventing air pollution-induced increase in IL-6; or reducing or preventing air pollution-induced cell damage; and a cosmetically acceptable carrier or excipient.
A61Q 17/00 - Préparations protectricesPréparations employées en contact direct avec la peau pour protéger des influences extérieures, p. ex. des rayons du soleil, des rayons X ou d'autres rayons nuisibles, des matériaux corrosifs, des bactéries ou des piqûres d'insectes
A61Q 19/02 - Préparations pour les soins de la peau pour décolorer ou blanchir la peau chimiquement
A61Q 19/08 - Préparations contre le vieillissement
A power dispensing closure capable of being retrofitted to existing powder containers to allow metered dispensing of powder from conventional powder containers. The closure may include a metering disk enclosed within an interior space, and movable between a closed position in which the metering disk may be loaded with powder material from the container and a dispense position in which the metering disk is capable of dispensing the loaded material from the closure. The closure may include a metering disk actuator extending from the metering disk through a slot in the housing. The closure may include a bottom housing configured to install on a powder container in place of a conventional cap. The housing may include a load opening for loading the metering disk and a spout for dispensing the loaded powder. The load opening and spout may be radially offset no more than about ninety degrees.
G01F 11/24 - Appareils qu'il faut actionner de l'extérieur, adaptés à chaque opération répétée et identique, pour mesurer et séparer le volume prédéterminé d'un fluide ou d'un matériau solide fluent à partir d'une alimentation ou d'un récipient sans tenir compte du poids, et pour fournir ce volume avec chambres de mesure se déplaçant au cours de l'opération du type à soupapes, c.-à-d. que la séparation est effectuée par des mouvements étanches aux fluides ou aux poudres dans lesquels la chambre de mesure tourne ou oscille pour un matériau solide fluent
G01F 11/00 - Appareils qu'il faut actionner de l'extérieur, adaptés à chaque opération répétée et identique, pour mesurer et séparer le volume prédéterminé d'un fluide ou d'un matériau solide fluent à partir d'une alimentation ou d'un récipient sans tenir compte du poids, et pour fournir ce volume
Salvia hispanicaSalvia hispanica L.) variety designated Rehnborg, seed thereof, hybrids thereof, products thereof, and cultivars derived therefrom. The Rehnborg variety has uniform white seed, greater seed mass, and greater seed yields compared to other typical chia varieties or wild-type chia.
A01H 5/00 - Angiospermes, c.-à-d. plantes à fleurs, caractérisées par leurs parties végétalesAngiospermes caractérisées autrement que par leur taxonomie botanique
C12N 15/82 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules végétales
Salvia hispanica L.) variety designated Rehnborg, seed thereof, hybrids thereof, products thereof, and cultivars derived therefrom. The Rehnborg variety has uniform white seed, greater seed mass, and greater seed yields compared to other typical chia varieties or wild-type chia.
A method is disclosed. The method is generally useful for modifying a skin microbiome. The method comprises administering a topical composition to a subject's skin. A topical composition is also disclosed. The topical composition may be used for the method. The topical composition comprises a population of microorganisms, a component obtained from the population of microorganisms, or a combination thereof. The population of microorganisms is generally a Corynebacterium species. The Corynebacterium species comprises at least about 90%, optionally at least about 97%, sequence identity to a 16S rRNA sequence (SEQ ID NO: 1).
A61K 8/99 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de micro-organismes autres que des algues ou des champignons, p. ex. à base de protozoaires ou de bactéries
A61Q 19/08 - Préparations contre le vieillissement
The present disclosure relates to a skin-cleansing device. The skin-cleansing device of the present disclosure comprises: a body on the end of which there is a cleansing unit, and on the inside of which is provided a first electrical-power storing unit for storing electrical power whereby the cleansing unit is made to vibrate; and a cradle on the inside of which is formed an accommodation space so as to hold the body, with the cleansing unit in a downward-facing state, and which is provided with a second electrical-power storing unit for storing electrical power whereby the first electrical-power storing unit is charged.
A47K 7/04 - Dispositifs de lavage ou nettoyage, à main ou mécaniques
A61L 2/10 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contactAccessoires à cet effet utilisant des phénomènes physiques des radiations des ultraviolets
A composition comprising an effective amount of a wheat peptide and an effective amount of fucoidan. The composition further comprises an effective amount of at least one component or extract from among white peony root, Magnolia officinalis or Asiatic pennywort herb in combination with the wheat peptide and fucoidan. The composition may prevent and reduce Helicobacter pylori infections as well as gastric mucosal injuries which are caused by non-steroidal anti-inflammatory drugs, drinking, unhealthy eating habits, and stress, may regulate oxidative stress markers and anti-inflammatory markers in subjects, inhibit the generation of interleukin 8 (IL-8) and malondialdehyde (MDA), and increase the generation of superoxide dismutase (SOD) and prostaglandin E2 (PGE2).
A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
A61K 8/368 - Acides carboxyliquesLeurs sels ou anhydrides dans lesquels le groupe carboxyle est directement lié aux atomes de carbone du cycle aromatique
A61K 8/92 - Huiles, graisses ou ciresLeurs dérivés, p. ex. produits d'hydrogénation
A composition for treating skin pigmentation, a method of forming the composition, and a method of treating skin pigmentation are disclosed. The composition comprises at least one pharmaceutically acceptable additive. The composition further comprises at least one melanin production inhibitor, which may be a depigmentation agent. The melanin production inhibitor is present in an amount effective to inhibit melanin production in human skin cells of a subject that is administered the composition. The melanin production inhibitor is selected from the group consisting of cyclovirobuxine D, lipoic acid, nuciferine, peimisine, oleuropein, Rhodiola algida extract, Rhodiola kirilowii (Regel) Maxim extract, Glycyrrhizae Radix et Rhizoma extract, Cirsii japonici herba extract, Platycladi semen extract, Synotis erythropappa extract, Astragali complanati semen extract, Plantaginis semen extract, Lycopi herba extract, Euryales semen extract, Cuscutae semen extract, Amomi fructus extract, Tara seed extract, Platycladi cacumen extract, Eucommiae cortex extract, Dioscoreae rhizoma extract, Cirsii herba extract, and combinations thereof.
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
A pressure vessel having an outer shell and a flexible inner liner. The outer shell and inner liner are configured so that the water passing through the water treatment system engages the inner liner, and not the outer shell. The inner liner is blow molded from a material that does not leach undesirable substances into the water flowing through the water treatment systems. The inner liner may include a receptacle portion to house one or more water treatment components. The receptacle portion may be flexible under the anticipated range of internal pressures. The receptacle portion may be disposed in the outer shell with the outer shell concealing expansion/contraction of the inner liner and providing the pressure vessel dimensional stability. The inner liner may include a rigid neck portion mounted to the outer shell. The outer shell and/or inner liner may include internal ribs configured to maintain spacing therebetween.
B01J 19/12 - Procédés utilisant l'application directe de l'énergie ondulatoire ou électrique, ou un rayonnement particulaireAppareils à cet usage utilisant des radiations électromagnétiques
B01J 3/02 - Dispositifs d'alimentation ou d'évacuation appropriés
B01J 3/03 - Récipients sous pression, ou récipients sous vide, comportant des organes de fermeture ou des joints d'étanchéité spécialement adaptés à cet effet
C02F 1/28 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par absorption ou adsorption
C02F 1/32 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par irradiation par la lumière ultraviolette
C02F 9/00 - Traitement en plusieurs étapes de l'eau, des eaux résiduaires ou des eaux d'égout
91.
COUPLING DETECTION FOR ULTRASOUND TREATMENT DEVICE
A system and method of detecting coupling between an ultrasound treatment device and human tissue using voltage and/or current feedback mechanism at a singular frequency. The method includes the general steps of: determining the appropriate drive frequency for a transducer, determining the decision boundary for that transducer at the determined drive frequency, applying a drive signal at the determined drive frequency, sensing the current and/or voltage of the drive signal at the determined drive frequency and determining status of coupling based on a comparison of the sensed current and/or voltage with the determined decision boundary. When the decision boundary has been crossed, an alarm may be presented and/or the power may be reduced or eliminated. Current and/or voltage measurements at a secondary drive frequency may be used and compared to a secondary decision boundary to improve accuracy in some applications.
An integrated system for delivering weight loss guidance and activity tracking in a mobile format. The integrated system includes a weight loss program hosted on a mobile device. The weight loss program includes an energy intake prescription to guide a participant toward a target weight according to a weight loss prediction model that is visually depicted in a first application window. The mobile device can be paired with a weight sensor to provide weight updates at regular intervals. The mobile device can also be paired with a caloric expenditure measuring device, for example a step counter, to display activity levels for comparison with recommended activity goals in a second application window. The weight loss program extends over multiple phases that are structured to help individuals gradually achieve a sustainable weight loss while increasing daily activity levels over the duration of the program.
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
G06F 3/0481 - Techniques d’interaction fondées sur les interfaces utilisateur graphiques [GUI] fondées sur des propriétés spécifiques de l’objet d’interaction affiché ou sur un environnement basé sur les métaphores, p. ex. interaction avec des éléments du bureau telles les fenêtres ou les icônes, ou avec l’aide d’un curseur changeant de comportement ou d’aspect
G06N 7/00 - Agencements informatiques fondés sur des modèles mathématiques spécifiques
G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p. ex. la physiothérapie, l’acupression ou les exercices
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
93.
BODY WEIGHT MANAGEMENT AND ACTIVITY TRACKING SYSTEM
An integrated system for delivering weight loss guidance and activity tracking in a mobile format. The integrated system includes a weight loss program hosted on a mobile device. The weight loss program includes an energy intake prescription to guide a participant toward a target weight according to a weight loss prediction model that is visually depicted in a first application window. The mobile device can be paired with a weight sensor to provide weight updates at regular intervals. The mobile device can also be paired with a caloric expenditure measuring device, for example a step counter, to display activity levels for comparison with recommended activity goals in a second application window. The weight loss program extends over multiple phases that are structured to help individuals gradually achieve a sustainable weight loss while increasing daily activity levels over the duration of the program.
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p. ex. la physiothérapie, l’acupression ou les exercices
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
94.
SYSTEM AND METHOD FOR MONITORING INTAKE COMPLIANCE
A product interaction monitor includes sensors for measuring characteristics related to the product and/or product package or other type of container. The product interaction monitor can be installed in a container cap and used to monitor events associated with the container such as product usage. The product interaction monitor can utilize multiple sensor outputs to increase the accuracy of the detection of the events. The product interaction monitor can be used to estimate product inventory or product usage and communicate information regarding the product and/or product usage to a local display or a remote computer.
A product interaction monitor includes sensors for measuring characteristics related to the product and/or product package or other type of container. The product interaction monitor can be installed in a container cap and used to monitor events associated with the container such as product usage. The product interaction monitor can utilize multiple sensor outputs to increase the accuracy of the detection of the events. The product interaction monitor can be used to estimate product inventory or product usage and communicate information regarding the product and/or product usage to a local display or a remote computer.
A61J 7/04 - Dispositions pour l'indication ou le rappel du moment où l'on doit prendre des médicaments, p. ex. distributeurs programmés
B65D 51/24 - Fermetures non prévues ailleurs combinées avec dispositifs auxiliaires pour des buts autres que la fermeture
B65D 41/04 - Capuchons ou couvercles en forme de capuchons filetés ou similaires, fixés par rotation
G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
G08B 21/24 - Alarmes aide-mémoire, p. ex. alarmes contre la perte
G16H 20/13 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients delivrés par des distributeurs
A61J 1/03 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques pour pilules ou comprimés
A61J 1/14 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques DétailsAccessoires à cet effet
A composition and a method for improving the gastrointestinal (Gl) health of a human subject by promoting the activity of amylolytic and short-chain fatty acid (SCFA) producing (e.g. acetogenic and/or butyrogenic) microbes in the Gl system of a human subject. The composition includes a mixture of microbiota accessible carbohydrates (MACs) that includes at least two different resistant starches and at least two different non-starch polysaccharides. A blend for inclusion in a dietary supplement includes, or is, the mixture.
Compositions for suppressing sebum production in skin (e.g., seborrheic skin), and minimizing glycation in skin (e.g., mature skin) with enhanced UV absorptive properties are described. In particular, the present invention relates to a composition containing a skin benefit agent that includes Lithospermum erythrorhizon. Also, methods of suppressing sebum production in skin (e.g., seborrheic skin) and minimizing glycation in skin (e.g., mature skin) by applying a composition to the skin, wherein the composition comprises an effective amount of a derivative of Lithospermum erythrorhizon are also described.
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
brevets
